Assoc. Prof. GÖZDE YALÇIN ÖZKAT

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Bischalcone derivatives with fluorine and methoxy functional groups: Synthesis, molecular docking, and biological evaluation as potential anticancer agents

Ozcan S., ANIL D., YALÇIN ÖZKAT G., Sanli F., Karatas O. F., BURMAOĞLU S.

Journal of Molecular Structure , vol.1329, 2025 (SCI-Expanded)

Determination of Novel SARS-CoV-2 Inhibitors by Combination of Machine Learning and Molecular Modeling Methods

Güner E., Özkan Ö., Yalçin Özkat G., Ölgen S.

Medicinal Chemistry , vol.20, no.2, pp.153-231, 2024 (SCI-Expanded) Sustainable Development

Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents

Yalcin-Ozkat G., Ersan R. H., Ülger M., Tezcan Ülger S., Burmaoğlu S., Yildiz I., et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , vol.41, no.7, pp.2667-2686, 2023 (SCI-Expanded) Sustainable Development

Mentha longifolia ssp. longifolia Essential Oil Components as Novel Carbonic Anhydrase Isoform i and IX Inhibitors: Biological and Molecular Docking Studies

Karaçelik A. A., Özkat G.

Letters in Drug Design and Discovery , vol.20, no.6, pp.767-778, 2023 (SCI-Expanded) Sustainable Development

Synthesis, Biological Activities, Antioxidant Properties, and Molecular Docking Studies of Novel Bis-Schiff Base Podands as Responsive Chemosensors for Anions

Yapar G., Demir N., Kiraz A., Yalçın Özkat G., Yildiz M.

JOURNAL OF MOLECULAR STRUCTURE , vol.1266, 2022 (SCI-Expanded) Sustainable Development

Computational studies with flavonoids and terpenoids as BRPF1 inhibitors: in silico biological activity prediction, molecular docking, molecular dynamics simulations, MM/PBSA calculations

Yalcin-Ozkat G.

SAR AND QSAR IN ENVIRONMENTAL RESEARCH , vol.33, no.7, pp.533-550, 2022 (SCI-Expanded) Sustainable Development

Synthesis, molecular docking and some metabolic enzyme inhibition properties of biphenyl-substituted chalcone derivatives

Burmaoğlu S., Kazancioğlu E. A., Kazancioğlu M. Z., Saglamtas R., Yalçin Özkat G., Gülçin I., et al.

JOURNAL OF MOLECULAR STRUCTURE , vol.1254, 2022 (SCI-Expanded) Sustainable Development

In Silico Studies to Develop New GSK3 beta Inhibitors Effective in the 's Disease

Ozkat G., Yildiz I.

LETTERS IN DRUG DESIGN & DISCOVERY , vol.19, no.8, pp.691-705, 2022 (SCI-Expanded) Sustainable Development

Molecular Modeling Strategies of Cancer Multidrug Resistance

Yalcin-Ozkat G.

DRUG RESISTANCE UPDATES , vol.59, 2021 (SCI-Expanded)

Discovery of 5-(or 6)-benzoxazoles and oxazolo[4,5-b]pyridines as novel candidate antitumor agents targeting hTopo II alpha

Karatas E., Foto E., Ertan-Bolelli T., Yalcin-Ozkat G., Yilmaz S., Ataei S., et al.

BIOORGANIC CHEMISTRY , vol.112, 2021 (SCI-Expanded)

Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents

Burmaoğlu S., Gobek A., Aydin B. O., Yurtoglu E., Aydin B. N., Ozkat G., et al.

BIOORGANIC CHEMISTRY , vol.111, 2021 (SCI-Expanded)

Spectroscopic, quantum mechanical studies, ligand protein interactions and photovoltaic efficiency modeling of some bioactive benzothiazolinone acetamide analogs

Mary Y. S., Yalcin G., Mary Y. S., Resmi K. S., Thomas R., Önkol T., et al.

CHEMICAL PAPERS , vol.74, no.6, pp.1957-1964, 2020 (SCI-Expanded) Sustainable Development

Synthesis and molecular docking studies of some novel antimicrobial benzamides

Acar C., Yalcin G., Ertan-Bolelli T., Kaynak Onurdağ F., Ökten S., Sener F., et al.

BIOORGANIC CHEMISTRY , vol.94, 2020 (SCI-Expanded) Sustainable Development

Molecular docking studies on fluoro-substituted chalcones as potential DprE1 enzyme inhibitors

Yalcin G., Burmaoğlu S., Yildiz I., Algul O.

JOURNAL OF MOLECULAR STRUCTURE , vol.1164, pp.50-56, 2018 (SCI-Expanded) Sustainable Development

Molecular dynamics, thermodynamic, and mutational binding studies for tumor-specific LyP-1 in complex with p32.

Timur S., Yalçın G., Çevik Ö., Andaç C., Gürsoy R.

Journal of biomolecular structure & dynamics , vol.36, pp.1134-1144, 2018 (SCI-Expanded) Sustainable Development

Determination of Antibiotic Resistance and Pulsed-Field Gel Electrophoresis Profiles for the Extended-Spectrum beta-Lactamase Producing Escherichia coli

Ozer T. T., Karagöz A., Yalcin G., Andac C. A.

JUNDISHAPUR JOURNAL OF MICROBIOLOGY , vol.11, no.3, 2018 (SCI-Expanded) Sustainable Development

Modification of benzoxazole derivative by bromine-spectroscopic, antibacterial and reactivity study using experimental and theoretical procedures

Aswathy V. V., Alper-Hayta S., Yalcin G., Mary Y. S., Panicker C. Y., Jojo P. J., et al.

JOURNAL OF MOLECULAR STRUCTURE , vol.1141, pp.495-511, 2017 (SCI-Expanded) Sustainable Development

Vibrational spectroscopic analysis, molecular dynamics simulations and molecular docking study of 5-nitro-2-phenoxymethyl benzimidazole

Menon V. V., Foto E., Mary Y. S., Karatas E., Panicker C. Y., Yalcin G., et al.

JOURNAL OF MOLECULAR STRUCTURE , vol.1129, pp.86-97, 2017 (SCI-Expanded) Sustainable Development

Articles Published in Other Journals

DRUG REPOSITIONING APPROACH FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS ANKİLOZAN SPONDİLİT TEDAVİSİNDE İLAÇ YENİDEN YERLEŞTİRME YAKLAŞIMI

Yalçin Özkat G.

Ankara Universitesi Eczacilik Fakultesi Dergisi , vol.46, no.3, pp.896-908, 2022 (Scopus)

DEVELOPMENT OF NEW CYCLOPHILIN D RECEPTOR INHIBITORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS MS HASTALIĞININ TEDAVİSİ İÇİN YENİ SİKLOFİLİN D RESEPTÖR İNHİBİTÖRLERİNİN GELİŞTİRİLMESİ

Yalçin Özkat G., Huylu B.

Ankara Universitesi Eczacilik Fakultesi Dergisi , vol.46, no.2, pp.458-473, 2022 (Scopus)

Molecular binding profile of protoberberine alkaloids on glycogen synthase kinase 3β as a drug candidate for alzheimer’s diseases Alzheimer hastaliğinda ilaç adayi olarak protoberberin alkaloitlerinin glikojen sentaz kinaz 3β ile moleküler bağlanma profilleri

Yalcin G., Yildiz I.

Ankara Universitesi Eczacilik Fakultesi Dergisi , vol.42, no.3, pp.1-12, 2018 (Scopus) Sustainable Development

Characterisation of drug resistance of nosocomial ESBL-producing E. coli isolates obtained from a Turkish university hospital between 2009 and 2012 by pulsed field gel electrophoresis and antibiotic resistance tests.

Karagöz A., Sunnetcioglu M., Ceylan M., Bayram Y., Yalcin G., Kocak N., et al.

Le infezioni in medicina , vol.24, pp.24-31, 2016 (Scopus) Sustainable Development

Current Trends In Fenugreek Bıotechnology And ApproachesTowards Its Improvement

Aasim M., Khawar K. M., Yalçin G., Bakhsh A.

american journal of social issues and humanities , no.3, pp.128-136, 2014 (Peer-Reviewed Journal) Sustainable Development

Refereed Congress / Symposium Publications in Proceedings

Molecular Docking Analysis of New Antibacterial Lead Compounds for Staphylococcus aureus

YALÇIN G., acar c., YILDIZ İ.

Eurasian Congress on Molecular Biotechnology, 19 - 21 September 2019

Glikojen Sentaz Kinaz 3 Beta İnhibitörleri Üzerine Hesaplamalı Farmakofor ModellemeÇalışmaları

YALÇIN G.

16. Ulusal Tibbi Biyoloji ve Genetik Kongresi, 27 - 30 October 2019

Some New Oxazolo[4,5-b]pyridines as Topoisomerase IIα Inhibitors

YILDIZ İ., Karataş E., FOTO E., YALÇIN G., Ataei S., ERTAN BOLELLİ T., et al.

7th Drug Chemistry Conference, Antalya/Kemer, Turkey, 14 - 17 March 2019

Some New Topoisomerase II Inhibitors

YILDIZ İ., KARATAS E., FOTO E., YALÇIN G., ATAEİ S., ERTAN BOLELLİ T., et al.

4th International Turkic World Conferenceon Chemical Sciences and Technologies, Kiev, Ukraine, 7 - 10 September 2018, pp.127

Molecular Binding Profile of Protoberberine Alkaloids on Receptor for Advanced Glycation Endproducts (RAGE) as a Drug Candidate for Alzheimer’s Diseases

YALÇIN G., DOĞRU B., YILDIZ İ.

International Chemistry Biology Conference’18, Şarm El-Şeyh, Egypt, 11 - 14 July 2018, pp.154

Glycogen Synthase Kinase 3 Beta inhibition by several acetylcholinesterase inhibitors

YALÇIN G., DOĞRU B., YILDIZ İ.

4th International Turkic World Conferenceon Chemical Sciences and Technologies, Kiev, Ukraine, 7 - 10 September 2018, pp.145

Investigation of Beta-secretase 1 Enzyme inhibition with known acetylcholinesterase inhibitors

YALÇIN G., YILDIZ İ.

4th International Turkic World Conferenceon Chemical Sciences and Technologies, Kiev, Ukraine, 7 - 10 September 2018, pp.146

Computational studies on glycogen synthase kinase 3 beta inhibitors

YALÇIN G., YILDIZ İ.

International Chemistry Biology Conference’18, Şarm El-Şeyh, Egypt, 11 - 14 July 2018, pp.153

Molecular binding profile of protoberberine alkaloids onglycogen synthase kinase 3β as a drug candidatefor Alzheimer’s diseases

YALÇIN G., YILDIZ İ.

7th InternationalMolecular Biology and BiotechnologyCongress, Konya, Turkey, 25 April - 27 September 2018, pp.42

Computational studies for drug design on beta-secretase 1 inhibition

YALÇIN G., YILDIZ İ.

Uluslar arası Katılımlı 6. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Antalya, Turkey, 22 - 25 March 2018, pp.119

DprE1-Benzimidazole derivatives interactions using molecular modelling

YALÇIN G., ERSAN R. H., ALGÜL Ö., YILDIZ İ.

Uluslar arası Katılımlı 6. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Antalya, Turkey, 22 - 25 March 2018, pp.120

Development of new lead BACE1 enzyme inhibitors

YALÇIN G., YILDIZ İ.

5th International BAU Drug Design Congress, 19 - 21 October 2017, pp.43

Pharmacophore Generation Studies for Developing of Potential BACE1 Enzyme Inhibitors

YALÇIN G., YILDIZ İ.

3rd International Turkic World Conference on Chemical Sciences and Technologies, 10 - 13 September 2017, pp.304

Molecular modelling studies on glycogen synthase kinase 3B inhibitors for Alzheimer’xxs Diseases

YALÇIN G., YILDIZ İ.

2nd International Gazi Pharma Symposium, 11 - 13 October 2017, pp.253

Protoberberine alkoloids as a drug candidate for Alzheimer’xxs Diseases

YALÇIN G., YILDIZ İ.

2nd International Gazi Pharma Symposium, 11 - 13 October 2017, pp.254

Molecular modelling studies on Glycogen Synthase Kinase 3β Inhibitors for Alzheimer’s Diseases

YALÇIN G., YILDIZ İ.

2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 October 2017

Pharmacophore Generation Studies for the Discovery of Potential BACE1 Enzyme Inhibitors

YALÇIN G., YILDIZ İ.

3rd International Turkic World Conferenceon Chemical Sciences Technologies, 10 - 13 September 2017

New nitro-benzoxazoles as antitumor agents targeting htopo II

KARATAS E., FOTO E., YALÇIN G., ZİLİFDAR F., ERTAN BOLELLİ T., YILDIZ İ.

17th Hellenic Symposium on Medicinal Chemistry (Designing targeted and safer drugs), Thessaloniki, Greece, 1 - 03 June 2017

Some New Benzoxazoles as Topoisomerase II Inhibitors

YILDIZ İ., KARATAS E., FOTO E., YALÇIN G., ZİLİFDAR F., ERTAN BOLELLİ T.

Uluslararası Katılımlı 5. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Antalya, Turkey, 30 March - 02 April 2017

Molecular Docking Studies on Some Benzimidazole Derivatives as Possible Decaprenylphoshoryl-D-ribose oxidase Enzyme Inhibitors

YALÇIN G., ERSAN R. H., YILDIZ İ., ALGÜL Ö.

5. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, 30 March - 02 April 2017

Molecular Docking Studies on Some Benzimidazole Derivatives as Possible Decaprenylphosphoryl-D-ribose oxidase Enzyme Inhibitors

YALÇIN G., Ersan R. H., YILDIZ İ., ALGÜL Ö.

Uluslararsı Katılımlı 5. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyon Kongresi, 30 March - 02 April 2017, pp.210

Molecular binding profile of protoberberine alkoloids on amyloid precursor proteincleaving enzyme 1 (BACE1) as a drug candidate for Alzheimer's diseases

YALÇIN G., YILDIZ İ.

41th FEBS CONGRESS The Biochemical Basis of Life, 23 September 2016, vol.283, pp.232

Pharmacophore Generation Studies For The Discovery Of Potential Acetylcholinesterase Inhibitors

YALÇIN G., YILDIZ İ.

3rd INTERNATIONALBAU-DRUG DESIGN CONGRESS, 01 October 2015

Inverse-agonistic mechanisms of thioridazine on Gi protein-coupled D2L dopamine receptors

YALÇIN G., ANDAC C. A.

40th FEBS CONGRESSThe Biochemical Basis of Life, Berlin, Germany, 04 July 2015, vol.282, pp.365

DOP-3 Homology Modelling and Explicit Solvent Molecular Dynamics of Stimulated Human Gi-coupled D2 Dopamine Receptor in a Membrane System

YALÇIN G., ANDAC C. A.

2nd INTERNATIONALBAU-DRUG DESIGN SYMPOSIUM, 17 October 2014

DETERMİNATİON OF BİNDİNG PROPERTİES OF BUTACLAMOL İN COMPLEX WİTH A MEMBRANE-BOUND HUMANGİ-COUPLED D2L DOPAMİNE RECEPTOR

YALÇIN G., ANDAC C. A.

8-th Eurasian Meeting on Heterocyclic Chemistry (EAMHC-2014), Tiflis, Georgia, 20 September 2014

ALA-SCAN mutational analysis on the agonist binding state of human Gi-coupled D2L dopamine receptor complex

YALÇIN G.

Workshop and Summer School on Protein Structure, Function, and Dynamics, 14 September 2014

Bütaclamolün İnsan Gi Proteini ve D2L Dopamin Reseptör Kompleksindeki Bağlanma Özelliklerinin Membran Simülasyonlarıyla Belirlenmesi

YALÇIN G., CENK A A.

8. Ulusal Afinite Teknikleri Kongresi, Konya, Turkey, 04 September 2014, pp.29

Books

Ilac tasarimi: hedefe erisimi optimize etmek

Yildiz I., Yalçin Özkat G.

in: Medisinal Kimya, Prof. Dr. Öztekin Algül, Editor, Ankara Nobel Tıp Kitabevleri, Ankara, pp.256-283, 2021 Sustainable Development

Hormonlar ve Endokrin Sistemi

Aasim M., Sadi G., Yalçin G.

in: BİYOLOJİ - Biology Schaum's Dördüncü Baskıdan Çeviri, Mehmet Karataş, Editor, Cheneliere/Mcgraw-Hill, Ankara, pp.286-303, 2015 Sustainable Development

Metrics

Publication

Citation (WoS)

234

H-Index (WoS)

Citation (Scopus)

293

H-Index (Scopus)

Citation (Scholar)

377

H-Index (Scholar)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works

Publication

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Project

Thesis Advisory

Open Access